Promising new cancer therapy appears to be extremely potent against tuberculosis

A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB).

Representatives concerned over DSCSA implementation and supply chain disruption

A group of bipartisan members of Congress, spearheaded by Reps. Troy Balderson (R-OH) and Ann Kuster (D-NH), sent a letter to FDA Commissioner Rob Califf

August 3, 2023

Bio-Thera, Biomm enter licensing deal for ustekinumab biosimilar

Bio-Thera’s BAT2206 is approved to treat moderate to severe plaque psoriasis patients aged six years or above. Credit: Ternavskaia Olga Alibec via shutterstock.com. Bio-Thera Solutions

June 19, 2023

Eleven stroke researchers to be recognized during the 2024 International Stroke Conference

Eleven scientists leading the way in stroke research will be recognized during the American Stroke Association’s International Stroke Conference 2024 for their exceptional professional achievements.

February 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.